Abstract 4527
Background
Malnutrition is very common in patients with cancer and is associated with an increase in morbidity and mortality, being directly responsible for death in up to 20% of cases. The presence of nutritional deficits in the initial stages of the tumor can condition tolerability to chemotherapy. The implementation of strategies to detect early malnutrition at all stages of the disease is essential to take measures to avoid their fatal consequences and to improve the quality of life of patients.
Methods
Analysis of the results obtained in the first nursing visit of 410 patients, between July 1, 2017 and May 1, 2018. Creation and completion of a standardized nursing assessment of all patients who come for the first time to a medical oncology consultation that includes: Nutritional status (MST - Malnutrition screening tool) Tumor and patient data BMI body mass index Changes in diet, types of changes ECOG Oncological treatment prescribed (standard or reduced dose).
Results
Patients with ≥2 MST are more likely to: have a higher age than the rest be men have a higher ECOG score have a reduced treatment dose have changed their diets.
Conclusions
The objective of the anaIysis is the identification of factors related to a higher probability of malnutrition in the first visit of nursing.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
5603 - Development of a comprehensive next-generation targeted sequencing assay for detection of gene-fusions in solid tumors
Presenter: Vinay Mittal
Session: Poster Display session 3
Resources:
Abstract
4952 - Next-generation sequencing for better treatment strategy of cancer of unknown primary (CUP)
Presenter: Kang Kook Lee
Session: Poster Display session 3
Resources:
Abstract
4590 - Circulating-free DNA analysis from long-term surviving metastatic colorectal cancer patients undergoing surgery for resectable disease.
Presenter: Michele Ghidini
Session: Poster Display session 3
Resources:
Abstract
3696 - Ultra-sensitive detection of circulating tumor DNA identifies patients in high risk of recurrence in early stages melanoma
Presenter: Filip Janku
Session: Poster Display session 3
Resources:
Abstract
4295 - Identification of the founder BRCA1 mutation c.4117G>T (p.Glu1373*) recurring in Abruzzo and Lazio regions of Central Italy and predisposing to breast/ovarian and BRCA1-related cancers
Presenter: Daniela Di Giacomo
Session: Poster Display session 3
Resources:
Abstract
2214 - Enzalutamide (ENZA) and Apalutamide (APA) In vitro chemical reactivity studies and Activity in a Mouse Drug Allergy Model (MDAM)
Presenter: Mausumee Guha
Session: Poster Display session 3
Resources:
Abstract
5044 - Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients.
Presenter: Bram Agema
Session: Poster Display session 3
Resources:
Abstract
3293 - Cardioprotective and anti-inflammatory effects of Empagliflozin during treatment with Doxorubicin: a cellular and preclinical study
Presenter: Vincenzo Quagliariello
Session: Poster Display session 3
Resources:
Abstract
3324 - Breast Cancer Organoids Model Treatment Response of HER2 Targeted Therapy in HER2-mutant Breast Cancer
Presenter: Xuelu Li
Session: Poster Display session 3
Resources:
Abstract
2115 - Preclinical in vivo screening to predict responder patients depend on EGFR status
Presenter: Yejin Kim
Session: Poster Display session 3
Resources:
Abstract